These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 362649)

  • 1. T-RFC monitoring of CMI events in renal allograft recipients.
    Kerman RH; Geis WP
    Transplant Proc; 1978 Sep; 10(3):633-5. PubMed ID: 362649
    [No Abstract]   [Full Text] [Related]  

  • 2. Active T and EA-rosette-forming cells in human cadaver renal allograft recipients.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1979 Feb; 35(2):236-41. PubMed ID: 373936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of T-cell-subset monitoring in renal-allograft recipients.
    Morris PJ; Carter NP; Cullen PR; Thompson JF; Wood RF
    N Engl J Med; 1982 May; 306(18):1110-1. PubMed ID: 7040954
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in peripheral blood T-cell rosettes in kidney allograft patients during the first postoperative month.
    Daudu P; Wright K; Geelhoed GW
    Am Surg; 1980 Dec; 46(12):697-707. PubMed ID: 7004286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and alterations of lymphocyte subpopulations in renal allograft recipients.
    Chatterjee SN; Gershwin ME; Eckles D
    Transplant Proc; 1979 Mar; 11(1):374-8. PubMed ID: 377659
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictive value of active T-RFC in renal allograft survival.
    Kerman RH; Ing TS; Hano JE; Geis WP
    Transplant Proc; 1978 Sep; 10(3):637-8. PubMed ID: 362650
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined immunologic and radionuclide techniques to monitor renal allograft rejection.
    Kerman RH; Floyd M; Conner W; McConnell R; McConnell BJ; Van Buren CT; Kahan BD
    Transplant Proc; 1979 Jun; 11(2):1229-31. PubMed ID: 382493
    [No Abstract]   [Full Text] [Related]  

  • 8. T-active rosette forming cells as a better index of kidney transplantation recipients' immune reactivity.
    Civati G; Brando B; Broggi ML; Cosci P; Minetti L
    Proc Eur Dial Transplant Assoc; 1980; 17():483-5. PubMed ID: 7017694
    [No Abstract]   [Full Text] [Related]  

  • 9. Antilymphocyte globulin (ALG) reverses "irreversible" allograft rejection.
    Light JA; Alijani MR; Biggers JA; Oddenino K; Reinmuth B
    Transplant Proc; 1981 Mar; 13(1 Pt 1):475-81. PubMed ID: 7022877
    [No Abstract]   [Full Text] [Related]  

  • 10. Does suppression of T-RFC determine in vivo immunosuppressive effect of ATG?
    Geis WP; Giacchino JL; Buckingham JM; Bansal VK; Iwatsuki S; Kerman RH; Ing TS; Hano JE
    Transplant Proc; 1979 Jun; 11(2):1433-4. PubMed ID: 382533
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal transplantation efficacy is dependent on pretransplantation immunologic monitoring.
    Drannik GN; Metodiev K; Nenov D; Baran EY
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1926-9. PubMed ID: 2652627
    [No Abstract]   [Full Text] [Related]  

  • 12. Different functional activities of T cell lines isolated from a rejected renal allograft and peripheral blood lymphocytes of renal transplant recipients.
    Miltenburg AM; Meijer-Paape ME; Daha MR; Paul LC
    Transplant Proc; 1988 Apr; 20(2):298-9. PubMed ID: 2966469
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cell electrophoresis studies of peripheral blood lymphocytes in patients following kidney transplantation].
    Templin R; Rychly J; Hudemann B; Bast R; Schmidt U; Thomaneck U; Schütt W
    Z Urol Nephrol; 1984 Mar; 77(3):145-9. PubMed ID: 6372311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [T- and B-lymphocytes in patients with chronic renal failure and in recipients of cadaveric allokidneys during the immediate posttransplant period].
    Dzerzhinskaia II
    Biull Eksp Biol Med; 1979 Feb; 87(2):174-6. PubMed ID: 369635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative evaluation of immunological methods of diagnosing kidney allograft rejection crises].
    Drannik GN; Baran EIa; Lukoskaia IG; Tkhor VA
    Urol Nefrol (Mosk); 1981; (4):18-23. PubMed ID: 7022990
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune monitoring after renal transplantation. I. HLA-D expression on T cells from renal allograft recipients.
    Nowaczyk M; Górski A; Modlińska M; Rancewicz Z; Bukowska J; Ołdakowska U; Morzycka-Michalik M; Lao M
    Arch Immunol Ther Exp (Warsz); 1991; 39(3):291-6. PubMed ID: 1667260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of the rosette inhibition test in renal allotransplantation.
    Cantaluppi A; Tarantino A; Donati D; Ponticelli C
    Transplant Proc; 1979 Mar; 11(1):379-81. PubMed ID: 377660
    [No Abstract]   [Full Text] [Related]  

  • 18. Individualized management of immunosuppression according to serial monitoring of immunocompetence.
    Cosimi AB; Delmonico FL; Burdick JF; Russell PS
    Transplant Proc; 1978 Sep; 10(3):647-50. PubMed ID: 362652
    [No Abstract]   [Full Text] [Related]  

  • 19. Effective monitoring and modulation of recipient immune reactivity to prevent rejection in early posttransplant period.
    Thomas F; Mendez-Picon G; Thomas J; Lee HM; Lower R
    Transplant Proc; 1978 Sep; 10(3):537-41. PubMed ID: 362632
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunological diagnosis of the kidney allograft rejection reaction].
    Drannik GN
    Urol Nefrol (Mosk); 1981; (5):64-71. PubMed ID: 6458144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.